BRAF RNA is prognostic and widely expressed in lung adenocarcinoma

BACKGROUND: BRAF is a critical member of proliferation pathways in cancer, and a mutation is present in only 2–4% of lung adenocarcinomas (LADC). There is no data available on the expression pattern of BRAF RNA that might result in enhanced signalling and drug resistance. METHODS: LADC tissue sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Dora, David, Vörös, Imre, Varga, Zoltán V., Takacs, Peter, Teglasi, Vanda, Moldvay, Judit, Lohinai, Zoltan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903089/
https://www.ncbi.nlm.nih.gov/pubmed/36762067
http://dx.doi.org/10.21037/tlcr-22-449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903089/
https://www.ncbi.nlm.nih.gov/pubmed/36762067
http://dx.doi.org/10.21037/tlcr-22-449

Ejemplares similares